Tb Lot Number Example

Understanding the Anatomy of a Research Peptide Lot Number

In analytical chemistry and preclinical research, a batch identifier or lot number is far more than a simple serial label. It represents a strict cryptographic link between a physical vial of lyophilized material and its full manufacturing history. When evaluating a high-purity compound like Thymosin Beta-4 (TB-500), the lot tracking code enables research personnel to verify raw material origins, solid-phase peptide synthesis (SPPS) parameters, purification conditions, and quality control test reports.

A compliant batch syntax standardizes internal inventory control across ISO 17025 accredited analytical facilities. Without an established lot nomenclature system, laboratory managers cannot guarantee batch-to-batch consistency across longitudinal animal assays or cell culture lines, making robust lot tracking indispensable for reproducible scientific literature.

Structural Breakdown: A Real-World TB Lot Number Example

To illustrate how leading synthesis facilities structure their tracking systems, consider the representative **tb lot number example**: `PX1-TB4-20241105-01A`. This code is deliberately segmented into specific data vectors designed for rapid identification during quality audit procedures:

1. Facility / Vendor Identifier (`PX1`): Designates PX1 Research as the primary source facility, confirming that the material was produced under strict U.S. manufacturing protocols. 2. Compound Code (`TB4`): Indicates the specific molecular entity—in this case, the 43-amino-acid peptide sequence corresponding to Thymosin Beta-4, or its truncated active fragment derivative TB-500. 3. Production Date Code (`20241105`): Specifies the completion date of the lyophilization and final packaging run (November 5, 2024). 4. Batch & Sub-Lot Suffix (`01A`): Indicates the primary synthesis run (01) and the specific aliquot batch or packaging sub-lot (A) used during automated vial filling.

By entering this exact sequence into an analytical database, researchers can instantly pull up the associated analytical Certificate of Analysis (COA) to inspect raw spectral outputs and purity scores.

Connecting Lot Numbers to Certificate of Analysis (COA) Verification

A lot number is only as reliable as the documentation attached to it. Every legitimate batch standard must be supported by an independent, lot-specific COA generated by an ISO 17025 certified laboratory. When inspecting a lot report for a compound like TB-500, cross-referencing the container's printed lot number against the header on the test report is the first mandatory quality gate.

The lot report must clearly display the identical lot number alongside raw analytical data, including high-performance liquid chromatography chromatograms and mass spectra. If a supplier provides a generic COA lacking a clear lot match, or presents a static batch report for multiple disparate orders, batch traceability is compromised, rendering the compound unsuitable for rigorous in vitro or in vivo experiments.

Analytical Testing Protocols: HPLC, Mass Spectrometry, and Endotoxin Standards

Verification of a research peptide lot requires rigorous orthogonal testing methods. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC purity analysis) is the industry standard for quantifying chemical purity. For research-grade TB-500, the HPLC chromatogram must show a single dominant integration peak representing ≥98.0% chemical purity, with minimal secondary peaks indicating truncation sequences or incomplete deprotection products.

Simultaneously, Electrospray Ionization Mass Spectrometry (ESI-MS) confirms molecular weight. Thymosin Beta-4 possesses an exact molecular weight of approximately 4963.5 Da. The mass spectrum in the lot documentation must display peak distribution matching this theoretical mass. Finally, because bacterial lipopolysaccharides can disrupt sensitive cell cultures and provoke confounding immune responses in animal models, lot-specific endotoxin testing protocols via Limulus Amebocyte Lysate (LAL) assays must confirm endotoxin levels below 0.01 EU/mg.

Preclinical Research Overview: Mechanisms of Thymosin Beta-4 and Derivatives

Thymosin Beta-4 (Tβ4) is a naturally occurring 43-amino acid peptide that acts as the primary G-actin sequestering molecule in eukaryotic cells. By binding monomeric actin in a 1:1 complex, Tβ4 regulates actin polymerization dynamics, which are critical for cell motility, cytoskeletal remodeling, and intracellular transport.

Preclinical models investigating Tβ4 and its synthetic analogues (such as the LKKTETQ active site fragment, often designated as TB-500) demonstrate significant activity in tissue repair assays. In vitro rodent dermal fibroblast models show enhanced cell migration upon peptide exposure, while in vivo corneal and cardiac lesion models suggest that Tβ4 upregulates matrix metalloproteinases (MMPs) and downregulates pro-inflammatory cytokines. All such findings in preclinical literature depend heavily on consistent, lot-verified peptide samples to ensure observable responses stem from the target sequence rather than synthesis contaminants.

Comparative Analysis: TB-500 vs. Related Regenerative Research Peptides

In preclinical studies examining tissue repair mechanisms and cellular migration, researchers frequently compare Thymosin Beta-4 derivatives against other well-characterized research compounds. Understanding the distinct biochemical pathways of each compound allows investigators to design targeted multi-agent or comparative in vitro panels.

For instance, while TB-500 operates primarily through actin sequestering and focal adhesion kinase modulation, BPC-157 acts largely via VEGFR2 pathway activation and early growth response-1 (EGR-1) gene expression. Simultaneously, copper-binding tripeptides such as GHK-Cu influence collagen synthesis and remodeling by regulating gene expression of decorin and metalloproteinases. To explore complete technical specifications across these target classes, laboratory managers can review our comprehensive research peptide catalog.

Handling, Reconstitution, and Storage Protocols for Lot-Verified Samples

To maintain the chemical integrity confirmed on the batch COA, laboratories must follow strict storage and preparation guidelines upon receipt of lot-tracked vials. Lyophilized peptides should be stored in desiccated conditions at -20°C to -80°C for long-term stability, protected from light exposure to prevent oxidative degradation.

When reconstituting, researchers should utilize bacteriostatic water or sterile phosphate-buffered saline (PBS) depending on the requirements of the planned assay system. The solvent should be gently directed against the glass wall of the vial rather than sprayed directly onto the peptide cake. Gentle swirl mixing is recommended; rigorous vortexing must be avoided to prevent mechanical shearing of the peptide chain. For step-by-step dilution formulas and molarity calculations, consult our dedicated peptide reconstitution guide.

Supply Chain Integrity and U.S. Manufacturing Standards at PX1 Research

Ensuring complete lot traceability requires full control over the manufacturing and distribution chain. PX1 Research manufactures research compounds in state-of-the-art, GMP-compliant domestic facilities located in the USA. By maintaining strict oversight over every phase of production—from initial amino acid coupling to final sterile filtration and lyophilization—PX1 eliminates the batch variance commonly seen with untraced imported peptides.

Every lot dispatched from our California and Arizona fulfillment centers undergoes third-party verification at an independent ISO 17025 accredited laboratory. Institutional buyers establishing bulk research accounts receive dedicated lot reservation services, ensuring that multi-stage longitudinal trials use peptides drawn from the exact same verified lot.